Evaluating the Scientific Evidence
for Potential Reduced-Risk Tobacco Products

Core Committee Meeting
April 27-28, 2005
Bethesda, MD


Dr. Falk: Welcome and participant introductions
(975K PDF File)*
Dr. St. Hilaire: Overview of the LSRO Reduced Risk Review Project
(547K PDF File)*
Dr. Mauderly: Laboratory animal models for assessing the relative health hazards of complex combustion/pyrolysis emissions
(967K PDF File)*
Dr. Kleinsasser: Genotoxic effects of nicotine in human target cells of carcinogenesis
(873K PDF File)*
Dr. Lauterbach: PREPS testing and the smaller tobacco companies
(108K PDF File)*
Mr. O'Reilly: British American Tobacco's approach to harm reduction and reduced-risk products
(294K PDF File)*
Mr. Massey: Evaluating smoking behavior and human smoke exposure for reduced risk products
(1,173K PDF File)*
Mr. Mariner: The evolving scientific paradigm for evaluating reduced risk products
(108K PDF File)*
Ms. Fisher: The need for scientific engagement in harm reduction
(74K PDF File)*
Mr. Emami: Biosynthec technology to reduce tobacco harm
(81K PDF File)*
Mr. Alexandrov: Biologic tests to prove efficacy of Biosynthec technology for tobacco harm reduction
(175K PDF File)*
Mr. Emami: The future of tobacco harm reduction technologies
(587K PDF File)*
Mr. Dillard: Risk reduction and smokeless tobacco
(15K PDF File)*
Dr. Abdallah: The role of blending and processing in developing reduced-risk cigarettes with acceptable smoking qualities
(577K PDF File)*

*Viewing and printing documents in PDF format requires Adobe® Acrobat® Reader® version 5.0+ which can be downloaded without cost from the Adobe web site.

Please note that some document files are very large, and you may experience correspondingly long download times. The file size is noted next to the link for each document.